Reference
- Garcia JR, Garcia AJ. Biomaterial-mediated strategies targeting vascularization for bone repair. Drug Deliv Transl Res. 2016;6(2):77–95.
- Bhardwaj N, Chouhan D, Mandal BB. Tissue engineered skin and wound healing: current strategies and future directions. CPD. 2017;23(24):3455–3482.
- Rouwkema J, Khademhosseini A. Vascularization and angiogenesis in tissue engineering: beyond creating static networks. Trends Biotechnol. 2016;34(9):733–745.
- Balaji S, King A, Crombleholme TM, et al. The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing. Adv Wound Care. 2013;2(6):283–295.
- Phng LK, Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev Cell. 2009;16(2):196–208.
- Novosel EC, Kleinhans C, Kluger PJ. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev. 2011;63(4-5):300–311.
- Xiao X, Wang W, Liu D, et al. The promotion of angiogenesis induced by three-dimensional porous beta-tricalcium phosphate scaffold with different interconnection sizes via activation of PI3K/Akt pathways. Sci Rep. 2015;5.
- Singh S, Wu BM, Dunn J. The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin. Biomaterials. 2011;32(8):2059–2069.
- Davies NH, Schmidt C, Bezuidenhout D, et al. Sustaining neovascularization of a scaffold through staged release of vascular endothelial growth factor-A and platelet-derived growth factor-BB. Tissue Engineering Part A. 2012;18(1-2):26–34.
- Perets A, Baruch Y, Weisbuch F, et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res. 2003;65A(4):489–497.
- Richards D, Jia J, Yost M, et al. 3D bioprinting for vascularized tissue fabrication. Ann Biomed Eng. 2017;45(1):132–147.
- Jang J, Park JY, Gao G, et al. Biomaterials-based 3D cell printing for next-generation therapeutics and diagnostics. Biomaterials. 2018;156:88–106.
- Frueh FS, Menger MD, Lindenblatt N, et al. Current and emerging vascularization strategies in skin tissue engineering. Crit Rev Biotechnol. 2017;37(5):613–625.
- Hirsh J, Anand SS, Halperin JL, et al. Guide to anticoagulant therapy: heparin. Circulation 2001;103(24):2994–3018.
- Janairo RRR, Henry JJD, Lee BL, et al. Heparin-modified small-diameter nanofibrous vascular grafts. IEEE Trans Nanobioscience. 2012;11(1):22–27.
- Hasan J, Shnyder SD, Clamp AR, et al. Heparin octasaccharides inhibit angiogenesis. In vivo. 2005;11(22):8172–8179.
- Liu H, Zhang Z, Linhardt RJ. Lessons learned from the contamination of heparin. Nat Prod Rep. 2009;26(3):313–321.
- Yang J, Xie Q, Zhu J, et al. Preparation and in vitro antioxidant activities of 6-amino-6-deoxychitosan and its sulfonated derivatives. Biopolymers. 2015;103(10):539–549.
- Jung BO, Na J, Kim CH. Synthesis of chitosan derivatives with anionic groups and its biocompatibility in vitro. J Ind Eng Chem. 2007;13(5):772–776.
- Ouerghemmi S, Dimassi S, Tabary N, et al. Synthesis and characterization of polyampholytic aryl-sulfonated chitosans and their in vitro anticoagulant activity. Carbohydr Polym. 2018;196:8–17.
- Qu G, Wu X, Yin L, et al. N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics. Biomed Pharmacother. 2012;66(1):46–51.
- Sun Z, Shi C, Wang X, et al. Synthesis, characterization, and antimicrobial activities of sulfonated chitosan. Carbohydr Polym. 2017;155:321–328.
- Tang T, Zhang G, Py Lau C, et al. Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells. Biomed Mater. 2011;6(1):015004.
- Doncel-Perez E, Aranaz I, Bastida A, et al. Synthesis, physicochemical characterization and biological evaluation of chitosan sulfate as heparan sulfate mimics. Carbohydr Polym. 2018;196(15):225–233.
- Xing R, Liu S, Yu H, et al. Preparation of high-molecular weight and high-sulfate content chitosans and their potential antioxidant activity in vitro. Carbohydrate Polymers. 2005;61(2):148–154.
- Terbojevich M, Carraro C, Cosani A, et al. Solution studies of chitosan 6-O-sulfate. Makromol Chem. 1989;190(11):2847–2855.
- Baumann H, Faust V. Concepts for improved regioselective placement of O-sulfo, N-sulfo, N-acetyl, and N-carboxymethyl groups in chitosan derivatives. Carbohydr Res. 2001;331(1):43–57.
- Deng FL, Zhou R, Lin C, et al. Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in clorectal cancer. Theranostics 2019;9(4):1001–1014.
- Zhang F, Lu YX, Chen Q, et al. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis. Cell Signal. 2017;36:67–78.
- Kim HS, Choi Y, Song IC, et al. Magnetic resonance imaging and biological properties of pancreatic islets labeled with iron oxide nanoparticles. NMR Biomed. 2009;22(8):852–856.
- Eldridge BN, Xing F, Fahrenholtz CD, et al. Evaluation ofmultiwalled carbon nanotube cytotoxicity in cultures of human brain microvascular endothelial cells grown on plastic or basement membrane. Toxicol Vitro. 2017;41:223–231.
- Chenmin Wang YY, Chen H, Zhang S, et al. Construction of cytokine reservoirs based on sulfated chitosan hydrogels for the capturing of VEGF in situ. J Mater Chem B. 2019;7(11):1882–1892.
- Yu YM, Chen J, Chen R, et al. Enhancement of VEGF-mediated angiogenesis by 2-N,6-O-sulfated chitosan-coated hierarchical PLGA scaffolds. ACS Appl Mater Interfaces. 2015;7(18):9982–9990.
- Taite LJ, Yang P, Jun H-W, et al. Nitric oxide-releasing polyurethane–PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. J Biomed Mater Res. 2008;84B(1):108–116.
- Wei Y, Ji Y, Xiao LL, Lin QK, et al. Surface engineering of cardiovascular stent with endothelial cell selectivity for in vivo re-endothelialisation. Biomaterials. 2013;34(11):2588–2599.
- Hoshi RA, Van Lith R, Jen MC, et al. The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts. Biomaterials. 2013;34(1):30–41..
- Seghezzi G, Patel S, Ren CJ, et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 1998;141(7):1659.
- Zhang W, Wray LS, Rnjak-Kovacina J, et al. Vascularization of hollow channel-modified porous silk scaffolds with endothelial cells for tissue regeneration. Biomaterials. 2015;56:68–77.
- Yu Y, Chen R, Sun Y, et al. Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan. Acta Biomater. 2018;71:510–521.
- Kitao A, Sato Y, Sawada-Kitamura S, et al. Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am J Pathol. 2009;175(2):616–626.
- Rack K, Huck V, Hoore M, et al. Margination and stretching of von Willebrand factor in the blood stream enable adhesion. Sci Rep. 2017;7(1):14278.
- Palmer BF, Clegg DJ. Oxygen sensing and metabolic homeostasis. Mol Cell Endocrinol. 2014;397(1-2):51–58.
- DeLisser HM, Newman PJ, Albelda SM. Platelet endothelial cell adhesion molecule (CD31). Curr Top Microbiol Immunol. 1993;184:37–45.
- Park S, Sorenson Christine M, Sheibani N. PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis. Clin Sci. 2015;129(3):217–234.
- Williamson MR, Black R, Kielty C. PCL–PU composite vascular scaffold production for vascular tissue engineering: Attachment, proliferation and bioactivity of human vascular endothelial cells. Biomaterials. 2006;27(19):3608–3616.
- Carano RAD, Filvaroff EH. Angiogenesis and bone repair. Drug Discovery Today. 2003;8(21):980–989.
- Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB. 1999;13(1):9–22.